VCP Scanner
Stock Screener
Filter stocks with fundamental & technical criteria
Technical Scanner
RSI, Moving averages & volume momentum signals
Market Themes
Curated industry baskets & thematic leaders
Earnings Hub
Calendar, EPS surprise stats & earnings transcripts
Market News
Real-time market intelligence & AI overviews
Insider Buying
SEC Form 4 corporate insider purchases
Minervini — VCPContraction bases in Stage 2 uptrends
Minervini — Trend TemplateFull 8-rule Stage 2 screen
O'Neil — Cup with HandleBase breakouts with RS leadership
O'Neil — CANSLIM LeadersGrowth leaders with RS ≥ 85
Qullamaggie — High Tight FlagsPower plays after a large advance
Qullamaggie — Momentum Leaders1/3/6-month strength leaders
Livermore — Pivotal PointsMulti-touch resistance breakouts
View All Playbooks...
Breakouts
FAANG & Tech
AAPL vs MSFTNVDA vs AMDGOOGL vs META
Cloud & Cyber
CRM vs NOWCRWD vs PANWSNOW vs DDOG
Consumer & Auto
TSLA vs FAMZN vs WMTNFLX vs DIS
Finance & Crypto
JPM vs BACV vs MACOIN vs MSTR
Index & ETFs
SPY vs QQQVTI vs VOOSPY vs IWM
Compare Any Stocks...
DCF ValuationCalculate intrinsic value of US stocks
Market ValuationBuffett indicator, CAPE & macro gauges
Total ReturnSee dividends + price return history
DCA CalculatorSimulate recurring buys & compounding
VisualizeInteractive multi-year financial charts
Watchlist
Breakouts
WatchlistPricing
Ctrl K
Pricing
MGTX
← Back to Screener
VCP ScannerFree US Stock Screener & Financial Analysis

Find stocks. Analyze deeply. Research with clarity.

Data updated daily

Product

  • Screener
  • Themes
  • Valuation
  • Total Return
  • DCA Calculator
  • Pricing
  • News
  • Earnings

Resources

  • Market Valuation
  • Compare
  • Insider Activity
  • Methodology
  • How It Works
  • Glossary
  • Learn

Get Ideas

Get weekly market insights — free

© 2026 VCP Scanner
AboutPrivacyTermsRefund Policy
Not financial advice. Do your own research.
ScreenerBreakoutsCompareWatchlist
MGTXMeiraGTx Holdings plc
$10.79$999M
Overview & Tools
OverviewChart Terminal ↗Visualize
Valuation & Forecasts
Valuation ModelsEstimatesDCF Model
Price & Analyst Data
Analyst TargetsPrice History
Financial Statements
Income StatementBalance SheetCash FlowRatios & Margins
Performance
P/E HistoryRevenue HistoryEarnings HistoryDividend HistoryTotal Return
Discovery & Screens
Live BreakoutsStock ScreenerOwnership
HomeStocksMGTXBalance Sheet

MeiraGTx Holdings plc (MGTX) Balance Sheet

10Y historyFree accessUpdated daily

The balance sheet is volatile, with equity swinging from -$58.1M in Q1 2026 to $215.6M in Q2 2026 due to milestone recognition, while a $112.3M debt load and a cumulative retained earnings deficit of -$701.8M highlight the company's reliance on external capital.

Income StatementBalance SheetCash FlowRatios

MGTX Balance Sheet

Annual statement

MGTX Balance Sheet

MeiraGTx Holdings plc (MGTX) balance sheet — 10-year assets, liabilities & shareholders' equity history

AnnualQuarterly
MetricTTMDec'25Dec'24Dec'23Dec'22Dec'21Dec'20Dec'19Dec'18Dec'17Dec'16
Total Current Assets218.35M91.76M123.52M159.62M154.34M183.24M272.58M268.98M74.65M11.48M19.09M
Cash & Short-Term Investments143.17M65.93M103.66M129.57M115.52M137.7M209.52M227.23M68.08M8.55M17.48M
Cash Only143.17M65.93M103.66M129.57M115.52M137.7M209.52M227.23M68.08M8.55M17.48M
Short-Term Investments00000000000
Accounts Receivable44.26M18.29M10.63M23.41M29.02M35.02M55.41M37.11M000
Days Sales Outstanding21.1982116.57609.72665.41339.021.3K1.02K---
Inventory00385K00000000
Days Inventory Outstanding--5.91--------
Other Current Assets26.93M1.53M2.02M1.02M1.67M2.42M564.44K170.59K4.63M965.23K400.96K
Total Non-Current Assets178.1M152.67M146.23M167.12M163.9M136.92M91.12M54.91M22.24M14.38M3.46M
Property, Plant & Equipment134.28M141.93M135.65M156.24M154.09M126.29M87.12M52.86M22.01M14.26M3.02M
Fixed Asset Turnover2.85x0.57x0.25x0.09x0.10x0.30x0.18x0.25x---
Goodwill00000000000
Intangible Assets421K578K821K1.12M2.08M2.57M2.97M777.65K000
Long-Term Investments62.35M6.75M6.75M6.77M6.33M6.66M0123.38K123.38K123.38K444.84K
Other Non-Current Assets3.56M3.41M3.01M3M1.4M1.4M1.03M1.15M105.08K00
Total Assets396.45M244.43M269.75M326.74M318.24M320.16M363.7M323.89M96.89M25.85M22.55M
Asset Turnover1.48x0.33x0.12x0.04x0.05x0.12x0.04x0.04x---
Asset Growth %62.6%-9.39%-17.44%2.67%-0.6%-11.97%12.29%234.27%274.77%14.65%-
Total Current Liabilities58.1M122.56M60.78M67.08M82.07M68.13M54.15M49.2M15.5M21.4M6.04M
Accounts Payable11.67M10.07M23.59M16.04M16.62M15.35M7.13M3.76M3.04M7.06M1.47M
Days Payables Outstanding490.05758.64361.85-----5413.79K2.21K
Short-Term Debt024.65M00002.58M1.67M27.2K1.44M0
Deferred Revenue (Current)11.95M1.78M4.83M2.93M15.12M21.82M23.54M25.68M11.99M10.19M-6.01K
Other Current Liabilities15.11M63.09M12.1M41.28M16.23M6.03M17.09M11.23M6.14M2.68M1.96M
Current Ratio3.76x0.75x2.03x2.38x1.88x2.69x5.03x5.47x4.82x0.54x3.16x
Quick Ratio3.76x0.75x2.03x2.38x1.88x2.69x5.03x5.47x4.82x0.54x3.16x
Cash Conversion Cycle-468.86--239.38--------
Total Non-Current Liabilities122.57M127.67M141.14M121.49M118.43M66.64M70.99M83.89M336.48K51.82M33.65M
Long-Term Debt100M49.69M73.22M72.12M71.03M000000
Capital Lease Obligations43.72M11.46M7.52M12.95M17.33M20.36M19.67M21.5M7.1K34.3K5.46K
Deferred Tax Liabilities0000186K196K213.72K195.05K-201.26K-266.29K-588.49K
Other Non-Current Liabilities1.45M1.4M2.82M2.4M2.44M3.03M1.81M1.65M329.38K51.78M33.64M
Total Liabilities180.67M250.22M201.92M188.57M200.5M134.76M125.14M133.09M15.84M73.22M39.69M
Total Debt112.32M88.69M84.8M89.26M92.25M23.73M22.25M23.18M34.3K1.51M11.47K
Net Debt-30.84M22.75M-18.86M-40.3M-23.27M-113.97M-187.27M-204.05M-68.05M-7.04M-17.47M
Debt / Equity0.52x-1.25x0.65x0.78x0.13x0.09x0.12x0.00x--
Debt / EBITDA0.41x----------
Net Debt / EBITDA-0.11x----------
Interest Coverage20.06x-8.36x-10.14x-5.34x-25.21x-275.25x-415.60x-1125.19x-2336.42x-739.21x-788.70x
Total Equity215.78M-5.79M67.83M138.18M117.74M185.4M238.56M190.8M81.06M-47.37M-17.14M
Equity Growth %6663.37%-108.54%-50.91%17.36%-36.5%-22.28%25.03%135.39%271.14%-176.36%-
Book Value per Share2.30-0.070.972.452.614.206.325.754.28-5.53-0.89
Total Shareholders' Equity215.57M-5.79M67.83M138.18M117.74M185.4M238.56M190.8M81.06M-47.37M-17.14M
Common Stock3K3K3K2K2K2K1.72K1.43K1.06K342342
Retained Earnings-701.82M-816.22M-702.02M-554.23M-470.2M-340.59M-261.03M-203.04M-148.29M-65.42M-34.38M
Treasury Stock-18.19M0000000000
Accumulated OCI3.25M2.41M-3.72M-1.44M6.05M-2.67M-4.9M-1.79M293.67K-2.02M-661.11K
Minority Interest209K0000000000

Key Metrics

Growth RegimeMixed
ProfitabilityStrained
Balance SheetMixed
Cash FlowBurning
Top Statement Risk

Imminent capital raise required

Verified Source

Metrics are mathematically derived from official filings.

SEC 10-K (2026Q2)

Balance Sheet Volatility Driven by Milestone Timing

The balance sheet has swung from a negative equity position of -$58.1M in Q1 2026 to a positive $215.6M in Q2 2026, a dramatic reversal driven by the recognition of a large non-cash revenue milestone from a partner, not by operational cash generation.

This extreme volatility in equity and total assets, which nearly doubled in a single quarter, underscores the company's reliance on lumpy, non-recurring collaboration payments to maintain its financial structure. The trajectory is not one of steady strengthening but of periodic, event-driven inflections that mask the underlying operational burn. Investors should monitor whether the next major milestone can be achieved before the current cash cushion is depleted.

Cash Position Rebuilt but Burn Rate Persists

Cash and equivalents surged to $143.2M in Q2 2026 from $71.5M in Q1, providing a temporary buffer, but the company's high fixed-cost structure and negative operating margins suggest this runway remains limited without further capital infusions.

The current ratio improved dramatically to 3.76, indicating strong short-term liquidity, but this is a direct result of the milestone cash inflow. The underlying operational burn, which averaged over $40M per quarter prior to Q2 2026, implies the current cash position may only fund operations for a few more quarters. The company's history of operating with a tight cash cushion warrants close monitoring for signs of another capital raise or asset sale.

Modest Leverage Amidst Equity Volatility

Total debt of $112.3M in Q2 2026 represents a manageable D/E ratio of 0.52, but this metric is highly volatile due to swings in equity, and the debt load appears strategic to fund the capital-intensive manufacturing infrastructure.

The debt level has remained relatively stable between $80M and $112M over the past ten quarters, suggesting it is a deliberate part of the capital structure rather than a sign of distress. However, the D/E ratio has been meaningless in quarters with negative equity, highlighting that leverage analysis must be paired with cash flow durability. The debt appears to be financing long-term assets like the manufacturing facilities, but its refinancing risk increases if clinical timelines extend.

Heavy Investment in Manufacturing Infrastructure

Property, plant, and equipment net of $134.3M constitutes over a third of total assets, reflecting the company's high-risk, vertically integrated strategy to own and operate its own cGMP manufacturing facilities.

This asset-heavy model creates a significant barrier to entry but also ties up substantial capital in facilities that are not yet generating commercial revenue. The quality of these assets is contingent on the clinical and commercial success of the pipeline; if programs fail, the PPE could become impaired. The minimal goodwill on the balance sheet suggests the asset base is primarily organic, reducing one type of intangible risk.

Massive Accumulated Deficit Undermines Equity Base

Retained earnings stand at a cumulative deficit of -$701.8M, indicating the company has consumed far more capital than it has generated since inception, a hallmark of a pre-revenue biotech funding its operations through equity and debt.

The equity base is fragile and highly sensitive to non-cash accounting events, as evidenced by the swing from negative to positive equity in a single quarter. The lack of positive retained earnings means the company has no internal buffer and is entirely dependent on external capital markets or strategic partnerships to fund its operations. This structure amplifies the risk for equity holders, as any future dilutive raise will occur from a position of historical capital consumption.

Deferred Revenue Decline Signals Partner Commitment Shift

Deferred revenue plummeted from $66.8M in Q1 2026 to $16.5M in Q2 2026, a $50.3M reduction that likely represents the recognition of previously deferred collaboration payments, but could also indicate a restructuring or termination of future obligations with a key partner.

This sharp decline is the most non-obvious risk on the balance sheet. While it likely reflects the recognition of revenue from the Janssen collaboration, it also means a significant portion of the company's future contracted revenue has now been earned and removed from the liability side. If this reflects a restructuring of the partnership, as hinted in recent context flags, it could signal a reduced commitment from a major partner and a future revenue cliff. This warrants investigation into the specific terms of the collaboration changes.

MGTX — Frequently Asked Questions

Quick answers to the most common questions about buying MGTX stock.

What are the total assets of MeiraGTx Holdings plc (MGTX)?

As of 2025, MeiraGTx Holdings plc (MGTX) had total assets of $244.4M including $91.8M in current assets.

How much debt does MeiraGTx Holdings plc (MGTX) have?

MeiraGTx Holdings plc (MGTX) carries total debt of $88.7M, offset by $65.9M in cash and short-term investments. Comparing total debt to cash helps evaluate the company's debt burden and net leverage.

What is the book value or shareholders' equity of MeiraGTx Holdings plc?

MeiraGTx Holdings plc (MGTX) has total shareholders' equity (book value) of $-5.8M ($-0.07 book value per share). Book value represents the net worth of the company belonging to common stock holders.

What is MeiraGTx Holdings plc's current ratio and liquidity?

MeiraGTx Holdings plc (MGTX) reported a current ratio of 0.75x. A current ratio above 1.0x indicates that the company has more current assets than current liabilities, suggesting sufficient short-term liquidity.